$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Stable adhesive contacts between cells and their surrounding extracellular matrix are required for maintenance of tissue homeostasis. For example, endothelial cell adhesion to the subendothelial matrix in blood vessels plays a critical role in maintaining the integrity of the endothelial layer and its homeostatic function as a regulatory, semi-permeable vascular barrier1. The actin cytoskeleton is mechanically coupled to adhesive matrix molecules at sites of cell-matrix adhesion and adhesive contacts at the cell-matrix interface play an important role in determining the position of the cell membrane by resisting centrally-directed actomyosin tensile forces. Extracellular stimuli that alter cell-matrix adhesion necessarily alter the balance of forces at the cell-matrix interface, an event that is rapidly ‘sensed’ by mechano-sensitive signaling proteins, resulting in the transduction of “outside-in signaling”. This cross-talk between cells and their surrounding extracellular matrix plays a key role in controlling cell shape, motility, function, proliferation and survival2.
Diverse patho-physiological processes (embryonic development, inflammation, wound repair and cancer metastasis) are characterized by dynamic remodeling of adhesive matrix substrates by matrix-degrading oxidants and/or enzymes3,4. For example, adhesive subendothelial matrix proteins in blood vessels (e.g., fibronectin) are implicated as major targets for modification or degradation in human inflammatory diseases due to the localized production of reactive oxidants (e.g., hypochlorous acid, HOCl) by the leukocyte-derived enzyme myeloperoxidase (MPO), which accumulates within the subendothelium during inflammatory vascular disease (Figure 1)5-9. Changes in cell-matrix adhesion induced by MPO-derived oxidants and other matrix-modifying stimuli are likely to play important roles in altering vascular homeostasis during a variety of pathological processes; e.g., by altering endothelial cell signaling, morphology and viability, which in turn perturbs endothelial function and barrier integrity. However, the morphological and cell signaling responses of adherent cells to extracellular matrix modifications are only beginning to be understood.
To understand how matrix modifications drive changes in cell adhesion dynamics and adhesion-dependent cell signaling pathways, techniques are required that accurately quantify changes in cell-matrix adhesion in real time, with high temporal resolution. Here, we describe complementary cell-substrate impedance and live cell imaging techniques that fulfill these criteria and provide a platform to quantify cell adhesion and de-adhesion processes in a non-invasive manner.
We show how these cell-substrate impedance and live cell imaging approaches can be readily employed to (i) monitor the dynamics of cell attachment and spreading (i.e., de novo cell adhesion) onto native and modified matrix substrates and (ii) to measure the dynamics of cell-matrix detachment (i.e., de-adhesion) by adherent cells exposed to matrix-modifying stimuli. The xCELLigence cell-substrate impedance biosensor system provides a continuous measurement of the area of cell-matrix contact by quantifying electrical impedance at the surface of 96-well gold microelectrode arrays and expresses these electrical impedance measurements as ‘cell index’, a dimensionless value that is largely proportional to the area of cell-substrate contact10 (Figure 2), whilst also being sensitive to changes in the average distance between the (insulating) cell membrane and the electrode surface11. A further increase in cell index values is also achieved upon formation of tight cell-cell contacts that restrict paracellular current flows,11 conditions that do not prevail within the experiments described in this study. Measurement of the projected area of individual cells over time by image analysis of time-lapse differential interference contrast (DIC) movies provides a complementary measure of changes in the area of cell-substrate contact and provides additional information regarding the precise nature and dynamics of the morphological changes quantified by the cell-substrate impedance approach.
Specifically, we describe the application of these approaches to monitor how MPO-mediated oxidation of adhesive subendothelial matrix proteins (e.g., fibronectin) (i) reduces the de novo adhesion of suspended endothelial cells onto purified fibronectin and (ii) triggers cell-matrix de-adhesion in endothelial cells with established adhesion on fibronectin. By performing parallel cell signaling analyses over time using relevant biochemical assays (e.g., Western blotting), the temporal and causal relationships between adhesion/de-adhesion processes and associated changes in adhesion-dependent cell signaling events can be determined.
These approaches were recently used to demonstrate that extracellular matrix oxidation catalyzed by subendothelial deposits of MPO triggers a rapid loss in cell-matrix adhesion of endothelial cells that is driven by pre-existing actomyosin contractile forces9. Importantly, by enabling the temporal relationship between changes in both cell adhesion and adhesion-dependent cell signaling to be determined, these approaches identified that MPO-induced matrix modification and cellular de-adhesion triggers changes in important adhesion-dependent cell signaling pathways including Src kinase-dependent paxillin phosphorylation and myosin light chain II phosphorylation (Figure 1)9. This mode of redox-dependent signaling, involving the activation of intracellular signaling events by extracellular oxidative reactions that disrupt cell-matrix adhesion, represents a novel mode of cell signaling termed “outside-in redox signaling” (Figure 1)9.
In general, these complementary cell-substrate impedance biosensor and live cell imaging approaches should be valuable in revealing how different matrix-modifying stimuli or agents drive changes in cell adhesion dynamics, morphology and signaling within different adherent cell-types subject to a wide variety of experimental settings.
The following protocol describes how to quantify the impact of MPO-mediated matrix oxidation on de novo endothelial cell adhesion (Experiment 1) and endothelial cell de-adhesion (Experiment 2) processes. MPO binds avidly to fibronectin and other adhesive subendothelial extracellular matrix proteins and uses hydrogen peroxide (H2O2) to convert chloride ions (Cl–) to the highly reactive chlorinating oxidant hypochlorous acid (HOCl), which reacts locally with these matrix proteins and disrupts their cell adhesive properties (Figure 1)8,9,12.